A skincare startup got bought for $190 million—then shut down. Here's what entrepreneurs can learn from the rise and fall of ...

Hims & Hers is shutting down Apostrophe, the skincare company it acquired in 2021, after a tumultuous month for the public telehealth company.

A view of the Hims smartphone app. Photo: Getty Images Hims & Hers Health will shut down Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. Apostrophe ...

Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operations, the ...

Hims & Hers Health (NYSE:HIMS) shut down Apostrophe on Friday, the skincare business it acquired in 2019 for $190M. A message at the top of Apostrophe's website says, "Apostrophe is being ...

March 7 (Reuters) - Hims & Hers Health (HIMS.N), opens new tab would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. Apostrophe is being ...

Apostrophe's services were discontinued on March 7 and customers will be able to access their accounts "for the next 30 days," a notice on the company's website says. San Francisco-based ...

(Reuters) -Hims & Hers Health would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on Friday. Apostrophe is being shut down to "simplify its ...

Apostrophe, a skin care telehealth brand headquartered in the Bay Area, is shutting down after almost four years under the Hims & Hers corporate umbrella. The skin care company, founded in ...

Hims & Hers is shutting down the dermatology business it acquired in 2021, BI has learned. It said it's closing the skincare site Apostrophe to centralize its teledermatology offerings. Hims ...